These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11027820)

  • 21. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
    Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
    J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
    Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
    Borrow R; Goldblatt D; Andrews N; Richmond P; Southern J; Miller E
    J Infect Dis; 2001 Aug; 184(3):377-80. PubMed ID: 11443568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
    Korkeila M; Lehtonen H; Ahman H; Leroy O; Eskola J; Käyhty H
    Vaccine; 2000 Jan; 18(13):1218-26. PubMed ID: 10649623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of vaccination on local immunity indices; the determination of antimeningococcal antibodies in saliva].
    Martynov IuV; Marinin IIu; Deviatkina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):55-8. PubMed ID: 1801492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
    Granoff DM; Gupta RK; Belshe RB; Anderson EL
    J Infect Dis; 1998 Sep; 178(3):870-4. PubMed ID: 9728562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults.
    Ferlito C; Biselli R; Cattaruzza MS; Teloni R; Mariotti S; Tomao E; Salerno G; Peragallo MS; Lulli P; Caporuscio S; Autore A; Bizzarro G; Germano V; Biondo MI; Picchianti Diamanti A; Salemi S; Nisini R; D'Amelio R
    Clin Exp Immunol; 2018 Dec; 194(3):361-370. PubMed ID: 30099753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior meningococcal A/C polysaccharide vaccine does not reduce immune responses to conjugate vaccine in young adults.
    Lakshman R; Burkinshaw R; Choo S; Finn A
    Vaccine; 2002 Nov; 20(31-32):3778-82. PubMed ID: 12399209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children.
    Käyhty H; Ahman H; Rönnberg PR; Tillikainen R; Eskola J
    J Infect Dis; 1995 Nov; 172(5):1273-8. PubMed ID: 7594664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine.
    Huang Q; Li D; Kang A; An W; Fan B; Ma X; Ma G; Su Z; Hu T
    J Control Release; 2013 Nov; 172(1):382-389. PubMed ID: 23511718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine.
    Dbaibo G; Van der Wielen M; Reda M; Medlej F; Tabet C; Boutriau D; Sumbul A; Anis S; Miller JM
    Int J Infect Dis; 2012 Aug; 16(8):e608-15. PubMed ID: 22704725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.
    Borrow R; Joseph H; Andrews N; Acuna M; Longworth E; Martin S; Peake N; Rahim R; Richmond P; Kaczmarski E; Miller E
    Vaccine; 2000 Dec; 19(9-10):1129-32. PubMed ID: 11137248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.
    Nurkka A; Lahdenkari M; Palmu A; Käyhty H;
    Vaccine; 2004 Dec; 23(3):298-304. PubMed ID: 15530671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.
    Broderick MP; Romero-Steiner S; Rajam G; Johnson SE; Milton A; Kim E; Choi LJ; Radin JM; Schmidt DS; Carlone GM; Messonnier N; Faix DJ
    Clin Vaccine Immunol; 2016 Aug; 23(8):672-80. PubMed ID: 27280619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
    Mulholland K; Suara RO; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen WP; Francis N; Fritzell B; Greenwood BM
    JAMA; 1996 Apr; 275(15):1182-8. PubMed ID: 8609686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.
    Twumasi PA; Kumah S; Leach A; O'Dempsey TJ; Ceesay SJ; Todd J; Broome CV; Carlone GM; Pais LB; Holder PK
    J Infect Dis; 1995 Mar; 171(3):632-8. PubMed ID: 7876610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.